For many years, a vast proportion of documents appear to say that Thyroid Eye Disease (TED) - also know under various other names such as Graves' Eye Disease or Graves' Ophthalmopathy - occurs in association with Graves' Disease - the disease which results in hyperthyroidism.
You can talk to doctors, specialist nurses, read documents from NHS and eye specialists, and almost always get that impression.
Very rarely do you see mention of the fact that it can, and does, occur in cases of Hashimoto's where the patient is definitively hypothyroid, and in people in which no thyroid disease has been been found - possibly never even suspected.
If this paper (which, at present needs to be treated cautiously as it is a pre-print) holds water, then there is a cascade of questions. I suggest some of the following:
If it is a hard association, then why is there also a tendency for TED to occur in those with Graves' disease? Does this lead us to wonder if HPV has a role in Graves' Disease?
Does HPV vaccination reduce the likelihood of suffering TED? Given the fairly widespread cover by HPV vaccines, especially in the younger population, this could be very important. Are we already seeing a reduction in TED in the age group who have widely received HPV vaccination?
(However, there is a large number of HPV variants and it will, of course, be necessary to consider whether they all have the same effects, or possibly just a few.)
Even if, in time, this is seen as something of a false dawn, I think it just might wake up research a bit.
A Novel Association Between Human Papillomavirus and Thyroid Eye Disease
Ishita Garg, Benjamin I Meyer, Ryan A Gallo, Sara T Wester, Daniel Pelaez
PMID: 38746201 PMCID: PMC11092719 DOI: 10.1101/2024.04.27.24306443
Abstract
Context: Thyroid eye disease (TED) is an autoimmune disease characterized by orbital inflammation and tissue remodeling. TED pathogenesis is poorly understood but is linked to autoantibodies to thyroid-stimulating hormone receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R).
Objective: To explore the potential involvement of viral infections in TED pathogenesis.
Methods: Using NCBI BLAST, we compared human TSHR and IGF-1R proteins to various viral proteomes, including Papillomaviridae , Paramyxoviridae , Herpesviridae , Enterovirus , Polyomaviridae , and Rhabdoviridae . Enzyme-linked immunoassays (ELISAs) were performed on orbital adipose tissue samples from 22 TED patients and controls to quantify antiviral antibody titers. Demographics and clinical data were reviewed.
Results: Homology analysis revealed conserved motifs between TSHR and IGF-1R with several viral proteins, particularly the human papillomavirus 18 (HPV18) L1 capsid protein. Basic demographic and clinical information between the cohorts were comparable. ELISAs showed statistically significant differences in the average HPV18 L1 IgG normalized optical density levels among tissues of control ( M = 0.9387, SD = 0.3548), chronic TED ( M = 2.305, SD = 1.064), and active acute TED ( M = 4.087, SD = 2.034) patients. These elevated HPV18 L1 IgG titers did not statistically correlate with TSH, T4, or TSI levels, and were elevated in TED patients irrespective of treatment with teprotumumab, indicating a direct immunological response to HPV.
Conclusions: This study presents the first molecular evidence linking HPV and TED, highlighting molecular mimicry between HPV capsid protein and key autoimmunity targets in TED. This suggests an immunological link contributing to TED's pathogenesis, opening new avenues for understanding and managing the disease.
pubmed.ncbi.nlm.nih.gov/387...
Full text currently accessible here:
medrxiv.org/content/10.1101...
I must re-emphasise that this is a pre-print and is liable to being edited, or retracted before publication, and links might not work into the future.